- ISIN
- BMG4690M1010
- CUSIP
- G4690M101
- Sector
- Technology
- Industry
- Information Technology Services
- IPO Date
- Aug 7, 2020
Highlights
- Market Cap
- $473.17M
- Enterprise Value
- $534.20M
- EPS (TTM)
- $3.19
- PE Ratio
- 11.07
- PEG Ratio
- 0.06
- Total Revenue (TTM)
- $626.95M
- Gross Profit (TTM)
- $133.71M
- EBITDA (TTM)
- $70.34M
- Year Range
- $25.94 - $42.99
- Target Price
- $24.00
- ROA (TTM)
- 15.87%
- ROE (TTM)
- 29.34%
- Avg. Volume (1M)
- 86K
- Avg. Volume Value (1M)
- $2.94M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IBEX Performance Chart
IBEX Limited (IBEX) is down 7.4% since the beginning of the year. At $35 per share, IBEX is trading 17.8% below its 52-week high of $43. Investors who bought $1,000 worth of IBEX shares 5 years ago would now be looking at an investment worth $1,713.
Loading charts...
Compare this symbol against anything
Returns By Period
IBEX Limited (IBEX) has returned -7.44% so far this year and 27.35% over the past 12 months.
IBEX Limited
- 1D
- -0.35%
- 1M
- 9.99%
- 6M
- -5.00%
- YTD
- -7.44%
- 1Y
- 27.35%
- 3Y*
- 21.75%
- 5Y*
- 11.37%
- 10Y*
- —
- ALL TIME*
- 11.94%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
IBEX Monthly Returns History
Based on dividend-adjusted daily data since Aug 7, 2020, IBEX's average daily return is +0.10%, while the average monthly return is +1.58%. At this rate, an investment would double in approximately 3.7 years.
Historically, 50% of months were positive and 50% were negative. The best month was Sep 2025 with a return of +37.2%, while the worst month was Feb 2026 at -22.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.
On a daily basis, IBEX closed higher 51% of trading days. The best single day was Sep 12, 2025 with a return of +36.5%, while the worst single day was Sep 14, 2023 at -25.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.57% | -22.31% | -7.20% | 3.47% | 14.02% | -4.01% | 16.36% | -7.44% | |||||
| 2025 | 2.42% | 14.99% | -3.79% | 2.83% | 14.98% | 1.08% | 1.62% | -0.14% | 37.22% | -7.77% | -5.83% | 8.50% | 77.66% |
| 2024 | -5.21% | -11.43% | -3.32% | -15.10% | 19.47% | 3.39% | 7.79% | -1.15% | 15.89% | -10.11% | 14.14% | 4.83% | 13.05% |
| 2023 | 7.40% | 4.72% | -12.70% | -16.11% | 0.05% | 3.66% | -6.50% | -1.46% | -21.01% | 5.63% | 8.64% | 7.22% | -23.50% |
| 2022 | 12.65% | 8.61% | 1.08% | -2.82% | 15.56% | -5.75% | 7.05% | -6.59% | 10.08% | 3.55% | 34.22% | -3.72% | 92.79% |
| 2021 | -1.50% | 19.49% | -0.05% | 5.00% | -5.89% | -10.21% | 5.69% | -12.85% | -5.45% | -4.41% | -18.62% | -2.53% | -31.07% |
Benchmark Metrics
IBEX Limited has an annualized alpha of 16.24%, beta of 0.67, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since August 07, 2020.
- This stock participated in 68.65% of S&P 500 Index downside but only 68.24% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.67 may look defensive, but with R2 of 0.04 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 16.24%
- Beta
- 0.67
- R²
- 0.04
- Upside Capture
- 68.24%
- Downside Capture
- 68.65%
Return for Risk
Risk / Return Rank
IBEX ranks 59 for risk / return — above 59% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for IBEX Limited (IBEX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBEX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.85 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.25 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.53 | 2.00 | -1.48 |
| Martin ratioReturn relative to average drawdown | 0.94 | 8.49 | -7.56 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the IBEX Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the IBEX Limited was 56.04%, occurring on Apr 17, 2024. Recovery took 266 trading sessions.
The current IBEX Limited drawdown is 15.86%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-56.04%Apr 2024 | 1y 1mo | 1y 22d | 2y 2moFeb 2023 - May 2025 | — |
-51.90%Dec 2021 | 7mo 17d | 11mo 24d | 1y 7moApr 2021 - Nov 2022 | — |
-48.50%Sep 2020 | 1mo 11d | 2mo 2d | 3mo 13dAug 2020 - Nov 2020 | — |
-37.14%Mar 2026 | 6mo 9d | — | 10mo 17dSep 2025 - now | — |
-19.18%Jan 2021 | 26d | 1mo 16d | 2mo 12dDec 2020 - Feb 2021 | — |
Drawdown Indicators
| IBEX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.04% | -56.78% | +0.74% |
Max Drawdown (1Y)Largest decline over 1 year | -37.14% | -9.10% | -28.04% |
Max Drawdown (3Y)Largest decline over 3 years | -37.14% | -18.90% | -18.24% |
Max Drawdown (5Y)Largest decline over 5 years | -56.04% | -25.43% | -30.61% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -15.86% | -1.58% | -14.28% |
Average DrawdownAverage peak-to-trough decline | -25.51% | -10.70% | -14.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.91% | 2.14% | +18.77% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of IBEX Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how IBEX Limited is priced in the market compared to other companies in the Information Technology Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for IBEX, comparing it with other companies in the Information Technology Services industry. Currently, IBEX has a P/E ratio of 11.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for IBEX compared to other companies in the Information Technology Services industry. IBEX currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IBEX relative to other companies in the Information Technology Services industry. Currently, IBEX has a P/S ratio of 0.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IBEX in comparison with other companies in the Information Technology Services industry. Currently, IBEX has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with IBEX
Add IBEX Limited to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IBEX